Loading...

Financial Summary


Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. (APVO)

Healthcare
Neutral
B
Market Info
Financial Info
Financial Modelling
Symbol APVO
Price 0.65$
Beta 2.92
Volume Avrg. 0.11M
Market Cap 0.01B
Shares (2018) 22,500.05K
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE -176.57% Strong Sell
ROA -147.98% Strong Sell
Operating Margin -223.98% Strong Sell
Debt / Equity 63.40% Buy
P/E - Neutral
P/B 0.95 Buy

Income Statement

Download APVO income statement Download APVO income statement
Year 2013 2014 2015 2016 2017 2018
Earnings Per Share Basic ---2.93-5.550.33-2.39
Net Profit Margin -313.75-1.12-1.77-11.260.48-2.33
Earnings Per Share Diluted ---2.93-5.550.33-2.39
Revenue 0.1745.6333.609.9814.6623.07
Weighted Average Shares Outstanding --20.2120.2521.4322.69
Gross Profit 0.1729.3816.67-2.489.6511.85
Weighted Average Shares Outstanding (Diluted) --20.2320.2421.3422.50
Sales, General and Administrative Expense 15.4534.2843.0436.1634.5828.13
Dividend per Share ------
Operating Income -53.34-51.71-61.10-138.77-53.95-51.66
Gross Margin 1.000.640.50-0.250.660.51
Earnings before Tax -53.34-51.71-61.34-132.11-16.33-53.69
EBITDA Margin -309.83-1.09-1.74-12.89-0.90-2.22
Net Income -53.34-51.12-59.32-112.426.97-53.69
EBIT Margin -313.75-1.13-1.83-13.23-1.11-2.33
Net Income - Discounted ops ------
Profit Margin -313.75-1.12-1.76-11.260.48-2.33
Preferred Dividends ------
Free Cash Flow margin -0.00-0.00-0.00-0.00-0.00-0.00
R&D Expenses 38.0746.5934.7329.1229.0235.38
Interest Expense ------
Earnings Before Tax Margin -313.75-1.13-1.83-13.23-1.11-2.33
Consolidated Income -53.34-51.12-59.32-112.426.97-53.69
EBIT -53.34-51.71-61.34-132.11-16.33-53.69
EBITDA -52.67-49.69-58.43-128.75-13.20-51.30
Income Tax Expense --0.60-2.02-19.69-23.30-
Operating Expenses 53.5181.0977.77136.2963.6063.52
Cost of Revenue -16.2516.9312.475.0111.21
Net Income Com -53.34-51.12-59.32-112.426.97-53.69
Net Income - Non-Controlling int ------

Balance Sheet Statement

Download APVO income statement Download APVO income statement
Year 2014 2015 2016 2017 2018
Total current liabilities 19.8419.9419.5418.5117.61
Other Liabilities 8.369.869.037.835.94
Long-term debt --18.3815.7319.28
Cash and cash equivalents 3.594.6410.087.5038.08
Total debt --18.3819.0619.28
Cash and short-term investments 3.594.6454.9281.1838.08
Deferred revenue 4.547.163.71--
Inventories 17.6320.320.461.031.78
Tax Liabilities 1.8715.82---
Goodwill and Intangible Assets 25.1246.656.916.085.25
Deposit Liabilities -----
Tax assets 1.311.38---
Total non-current liabilities 5.5319.2121.7516.4619.48
Total current assets 78.4292.6320.4421.9218.80
Total liabilities 25.3639.1541.2934.9737.09
Payables 11.4710.0810.527.3511.67
Other comprehensive income ---0.03-0.10-
Short-term investments --44.8573.69-
Retained earnings (deficit) -172.67-231.99-80.69-73.72-127.41
Property, Plant & Equipment Net 3.204.185.915.845.20
Total non-current assets 5.5319.2121.7516.4619.48
Other Assets 6.513.7215.7210.733.60
Net Debt -3.59-4.64-36.54-62.12-18.80
Investments --44.8583.69-
Total shareholders equity 94.6188.6250.5782.0330.41
Total assets 119.97127.7791.86117.0167.49
Long-term investments ---10.00-
Receivables 13.826.460.312.145.22
Short-term debt ---3.33-

Cash Flow Statement

Download APVO income statement Download APVO income statement
Year 2013 2014 2015 2016 2017 2018
Insurance (repayment) of debt ------
Net Cash/Marketcap 0.000.000.000.000.000.00
Insurance (buybacks) of shares ------
Depreciation & Amortization 0.672.022.913.363.132.39
Dividend payments ------
Operating Cash Flow -51.39-47.01-48.76-36.86-41.57-51.42
Acquisitions and disposals --47.81--59.760.07
Free Cash Flow -52.41-48.00-50.29-39.37-42.98-52.40
Net cash flow / Change in cash -3.591.045.047.4220.59
Effect of forex changes on cash ------
Financing Cash Flow 52.4199.4051.3389.3019.53-0.79
Investment purchases and sales ----44.88-28.9073.71
Capital Expenditure -1.02-0.99-1.53-2.51-1.40-0.98
Stock-based compensation 0.951.071.113.814.882.14
Investing Cash Flow ------

Retained Earning Schedule

Year 2014 2015 2016 2017 2018
Retained Earnings (Previous Year) --173-232-81-74
Net Income -51-59-1127-54
Stock Dividends -122-264--
Divident Paid -----
Retained Earnings -173-232-81-74-127

PPE Schedule

Year 2014 2015 2016 2017 2018
Year 20142015201620172018
Gross PPE -3466
Annual Depreciation 43410
Capital Expenditure -1-2-3-1-1
Net PPE 34665

Intangible and Goodwill Schedule

Year 2014 2015 2016 2017 2018
Intangible and Goodwill (Previous Year) -254776
New Purchases ---45-2974
Intangible and Goodwill 2547765
Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. (APVO)

0.65
0 (-0.18%)

About


Marvin L. White
Healthcare
Biotechnology
Nasdaq Global Select

Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.